2-pyrrolidinone derivatives substituted at position 4 for reducing the extracellular glutamate level

2-pyrrolidinone derivatives substituted at position 4 for reducing the extracellular glutamate level

2-pyrrolidinone derivatives which have in position 4 at least one substituent are described herein. Methods of treating polygltamine disorders such as Huntington's disease, dentorubropallidoluysian atrophy (DRPLA), spinal and bulbar muscular atrophy (SBMA), and spinocerebellar ataxias with 2-py...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KNOERLE RAINER, FEUERSTEIN THOMAS J
Format: Patent
Sprache:eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator KNOERLE RAINER
FEUERSTEIN THOMAS J
description 2-pyrrolidinone derivatives which have in position 4 at least one substituent are described herein. Methods of treating polygltamine disorders such as Huntington's disease, dentorubropallidoluysian atrophy (DRPLA), spinal and bulbar muscular atrophy (SBMA), and spinocerebellar ataxias with 2-pyrrolidinone derivatives are also descibed.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US6984659B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US6984659B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US6984659B23</originalsourceid><addsrcrecordid>eNqNyzEOwjAQBdE0FAi4w14gTQgRaUEgeqCOTPyTrLTYlr2O4PZQcACqad4sC1uV4R2jF7bsvANZRJ6N8oxEKT-SsmaFJaMUfGJl76imwUeKsLlnN5JOILw0mh4iWUykUbKap1GQYIasi8VgJGHz66qg8-l2vJQIvkMK39FBu_u1afd1s2sP1fYP8gHnTD-Z</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>2-pyrrolidinone derivatives substituted at position 4 for reducing the extracellular glutamate level</title><source>esp@cenet</source><creator>KNOERLE RAINER ; FEUERSTEIN THOMAS J</creator><creatorcontrib>KNOERLE RAINER ; FEUERSTEIN THOMAS J</creatorcontrib><description>2-pyrrolidinone derivatives which have in position 4 at least one substituent are described herein. Methods of treating polygltamine disorders such as Huntington's disease, dentorubropallidoluysian atrophy (DRPLA), spinal and bulbar muscular atrophy (SBMA), and spinocerebellar ataxias with 2-pyrrolidinone derivatives are also descibed.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2006</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20060110&amp;DB=EPODOC&amp;CC=US&amp;NR=6984659B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20060110&amp;DB=EPODOC&amp;CC=US&amp;NR=6984659B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KNOERLE RAINER</creatorcontrib><creatorcontrib>FEUERSTEIN THOMAS J</creatorcontrib><title>2-pyrrolidinone derivatives substituted at position 4 for reducing the extracellular glutamate level</title><description>2-pyrrolidinone derivatives which have in position 4 at least one substituent are described herein. Methods of treating polygltamine disorders such as Huntington's disease, dentorubropallidoluysian atrophy (DRPLA), spinal and bulbar muscular atrophy (SBMA), and spinocerebellar ataxias with 2-pyrrolidinone derivatives are also descibed.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2006</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyzEOwjAQBdE0FAi4w14gTQgRaUEgeqCOTPyTrLTYlr2O4PZQcACqad4sC1uV4R2jF7bsvANZRJ6N8oxEKT-SsmaFJaMUfGJl76imwUeKsLlnN5JOILw0mh4iWUykUbKap1GQYIasi8VgJGHz66qg8-l2vJQIvkMK39FBu_u1afd1s2sP1fYP8gHnTD-Z</recordid><startdate>20060110</startdate><enddate>20060110</enddate><creator>KNOERLE RAINER</creator><creator>FEUERSTEIN THOMAS J</creator><scope>EVB</scope></search><sort><creationdate>20060110</creationdate><title>2-pyrrolidinone derivatives substituted at position 4 for reducing the extracellular glutamate level</title><author>KNOERLE RAINER ; FEUERSTEIN THOMAS J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US6984659B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2006</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>KNOERLE RAINER</creatorcontrib><creatorcontrib>FEUERSTEIN THOMAS J</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KNOERLE RAINER</au><au>FEUERSTEIN THOMAS J</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>2-pyrrolidinone derivatives substituted at position 4 for reducing the extracellular glutamate level</title><date>2006-01-10</date><risdate>2006</risdate><abstract>2-pyrrolidinone derivatives which have in position 4 at least one substituent are described herein. Methods of treating polygltamine disorders such as Huntington's disease, dentorubropallidoluysian atrophy (DRPLA), spinal and bulbar muscular atrophy (SBMA), and spinocerebellar ataxias with 2-pyrrolidinone derivatives are also descibed.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US6984659B2
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title 2-pyrrolidinone derivatives substituted at position 4 for reducing the extracellular glutamate level
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T15%3A21%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KNOERLE%20RAINER&rft.date=2006-01-10&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS6984659B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true